Connecticut · Senate Bill 451 · 2026 Regular Session
AN ACT ESTABLISHING AN ADVISORY COUNCIL ON CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY AND OTHER GENE THERAPIES.
- Introduced Mar 4, 2026
- In committee Mar 5, 2026
- Died
- Passed the House
- To the governor
- Became law
What it does
The legislature's own summary of the bill, or its official long title.
To establish an advisory council on access to chimeric antigen receptor T-cell therapy and other gene therapies for the treatment of cancer.
Every action
9 steps, oldest first, as the legislature records them.
- CommitteeReferred to Joint Committee on Public Health · Joint Public Health Committee
- Public Hearing 03/13
- CommitteeJoint Favorable · Joint Public Health Committee27–5 vote
- Legislative Commissioners' OfficeFiled with Legislative Commissioners' Office
- Legislative Commissioners' OfficeReferred to Office of Legislative Research and Office of Fiscal Analysis 04/08/26 5:00 PM
- Legislative Commissioners' OfficeReported Out of Legislative Commissioners' Office
- SenateFavorable Report, Tabled for the Calendar, Senate
- SenateSenate Calendar Number 332
- Legislative Commissioners' OfficeFile Number 566
Roll calls
1 recorded vote: 0 on the floor, 1 in committee. Each shows how every member voted.
Committee votes
| Date | Where | Question | Result |
|---|---|---|---|
| Mar 23, 2026 | Joint Public Health Committee | Joint Favorable MembersYes · 27
No · 5 |
27–5 |
Sponsors
The 0 members who introduced it, joined by 1 cosponsor: 1 Democrat.
- PH Public Health Committee Sponsoring committee
All 1 cosponsor
From Connecticut's official records (www.cga.ct.gov), checked Nov 13, 2026. Text links go to the official versions; LegiList does not copy bill text.